Background Andrographolide (Andro), a diterpenoid lactone, continues to be employed for treatment of varied malignancies with less undesireable effects. Furthermore, Andro could inhibit COX-2-mediated angiogenesis in individual endothelial cells dose-dependently. We’ve also discovered that Andro considerably marketed the activation of…